David A Weinstein

6PUBLICATIONS
25CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Electrochemical energy storage and conversionFood packaging, preservation and processingNutrition and dietetics not elsewhere classifiedGenetically modified animals
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa.

|Mar 10, 2025
Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa).

David A Weinstein, Terry G Derks, David F Rodriguez-Buritica

|Jul 09, 2024
Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.

D A Weinstein, R J Jackson, E A Brennan

|Nov 12, 2021
Ketotic hypoglycemia in patients with Down syndrome.

Danielle Drachmann, Austin Carrigg, David A Weinstein

|May 27, 2018
Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia.

Young Mok Lee, Thomas J Conlon, Andrew Specht

|Jun 02, 2017
Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control.

M Dambska, E B Labrador, C L Kuo

Pageof 1

Frequent Collaborators

1 joint publications

Danielle Drachmann

1 joint publications

John J Mitchell

1 joint publications

Foekje de Boer

1 joint publications

Margo Sheck Breilyn